<!DOCTYPE html>
<html>
<head>
    <title>S&#x2019;pore firm en&#xAD;ters fi&#xAD;nal stage of clin&#xAD;i&#xAD;cal trial of Covid-19 an&#xAD;ti&#xAD;body - PressReader</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20201212/281732682070367" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>S&#x2019;pore firm en&#xAD;ters fi&#xAD;nal stage of clin&#xAD;i&#xAD;cal trial of Covid-19 an&#xAD;ti&#xAD;body</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20201212/textview" title="The Straits Times - 2020-12-12"><time>2020-12-12</time></a>
        - <span>THE BIG STORY</span>
        - <span role="byline">Jessie Lim jessie@sph.com.sg</span>
    </section>

    <p>The fi­nal phase of the clin­i­cal trial for a Covid-19 an­ti­body de­vel­oped by Sin­ga­pore biotech­nol­ogy com­pany Ty­chan be­gan yes­ter­day.</p>
    <p>The an­ti­body can po­ten­tially help pa­tients with the coro­n­avirus to re­cover faster, while slow­ing the pro­gres­sion of the in­fec­tion.</p>
    <p>Some 1,305 pa­tients who have tested pos­i­tive for Covid-19 will take part vol­un­tar­ily in the clin­i­cal tri­als.</p>
    <p>If the clin­i­cal tri­als are suc­cess­ful, the an­ti­body will be sub­mit­ted for re­view by the Health Sciences Author­ity (HSA) and other reg­u­la­tory agencies as a new drug.</p>
    <p>In Oc­to­ber, HSA gave Ty­chan the green light to start fi­nal-stage tri­als.</p>
    <p>The Sin­ga­pore Gen­eral Hos­pi­tal and Na­tional Univer­sity Hos­pi­tal have part­nered Ty­chan for the tri­als, while Changi Gen­eral Hos­pi­tal and Sengkang Gen­eral Hos­pi­tal may re­fer suit­able pa­tients for par­tic­i­pa­tion.</p>
    <p>A six-week phase one trial in</p>
    <p>June with 23 healthy vol­un­teers yielded good out­comes in terms of safety, said Ty­chan co-founder Ooi Eng Eong.</p>
    <p>Clin­i­cal tri­als are com­monly con­ducted in three phases, be­gin­ning with a small group to test the drug’s safety and side ef­fects, then mov­ing on to larger groups to de­ter­mine its ef­fi­cacy.</p>
    <p>Usu­ally, in phase three, what is be­ing tested is whether the drug works as in­tended in pre­vent­ing dis­ease or ac­cel­er­at­ing re­cov­ery.</p>
    <p>Un­like the pre­vi­ous tri­als, phase three will also in­volve pa­tients from part­ner hos­pi­tals over­seas such as the Sheba Med­i­cal Cen­tre in Is­rael.</p>
    <p>“Be­cause Sin­ga­pore has been suc­cess­ful in con­tain­ing Covid-19, there has been very low in­ci­dence of the dis­ease,” said Pro­fes­sor Ooi, who is with the Duke-NUS Med­i­cal School.</p>
    <p>He added that Ty­chan is ex­plor­ing col­lab­o­ra­tions with other med­i­cal fa­cil­i­ties in coun­tries where Covid-19 in­ci­dence re­mains high.</p>
    <p>The Ministry of De­fence, Ministry of Health and the Eco­nomic Devel­op­ment Board are among var­i­ous part­ners Ty­chan is work­ing with to de­velop the an­ti­body.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
